增殖性干样浆细胞在复发或难治性多发性骨髓瘤中的作用:来自单细胞RNA测序和蛋白质组分析的见解
研究整合15例浆细胞疾病患者的单细胞RNA测序数据与144例浆细胞疾病患者CD138+浆细胞的质谱蛋白质组数据,鉴定出复发或难治性多发性骨髓瘤中高干性评分且增殖增加的恶性浆细胞状态,命名为增殖性干样浆细胞(PSPCs)。NUCKS1被确定为代表PSPCs干性的基因标志,LGALS1在PSPCs中显著升高并与不良预后相关,MDK信号通路网络中三个配体-受体对参与PSPCs与微环境细胞的通讯。
要点
- 鉴定出RRMM中高干性评分且增殖增加的恶性浆细胞状态PSPCs。
- NUCKS1为PSPCs干性的基因标志,LGALS1在PSPCs中显著升高。
- LGALS1在MMRF CoMMpass和GSE24080数据集中与不良预后相关。
核心结论
- 研究鉴定了RRMM中具有高干性评分和增殖增加的增殖性干样浆细胞(PSPCs)状态,并发现LGALS1与多发性骨髓瘤不良预后相关,MDK信号通路中三个配体-受体对参与PSPCs与微环境细胞的通讯。
研究设计与样本
- 整合15例浆细胞疾病患者的单细胞RNA测序数据与144例浆细胞疾病患者CD138+浆细胞的质谱蛋白质组数据进行分析。
- 利用MMRF CoMMpass数据集和GSE24080数据集进行生存分析。
主要发现
- PSPCs为起源于RRMM的恶性浆细胞状态,以高干性评分和增殖增加为特征。
- NUCKS1被确定为代表PSPCs干性的基因标志。
- PSPCs中LGALS1表达显著升高。
- LGALS1在MMRF CoMMpass和GSE24080数据集中与多发性骨髓瘤不良预后相关。
- 在MDK信号通路网络中发现三个配体-受体对,在促进PSPCs与周围微环境细胞间高效通讯中发挥不同作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The management and comprehension of relapsed or refractory multiple myeloma (RRMM) continues to pose a significant challenge. By integrating single-cell RNA sequencing (scRNA-seq) data of 15 patients with plasma cell disorders (PCDs) and proteomic data obtained from mass spectrometry-based analysis of CD138+ plasma cells (PCs) from 144 PCDs patients, we identified a state of malignant PCs characterized by high stemness score and increased proliferation originating from RRMM. This state has been designated as proliferating stem-like plasma cells (PSPCs). NUCKS1 was identified as the gene marker representing the stemness of PSPCs. Comparison of differentially expressed genes among various PC states revealed a significant elevation in LGALS1 expression in PSPCs. Survival analysis on the MMRF CoMMpass dataset and GSE24080 dataset established LGALS1 as a gene associated with unfavourable prognostic implications for multiple myeloma. Ultimately, we discovered three specific ligand-receptor pairs within the midkine (MDK) signalling pathway network that play distinct roles in facilitating efficient cellular communication between PSPCs and the surrounding microenvironment cells. These insights have the potential to contribute to the understanding of molecular mechanism and the development of therapeutic strategies involving the application of stem-like cells in RRMM treatment.
引用
- Xu J, Li P, Wang Y, et al. The role of proliferating stem-like plasma cells in relapsed or refractory multiple myeloma: Insights from single-cell RNA sequencing and proteomic analysis. Br J Haematol. 2024. PMID: 38671576. doi:10.1111/bjh.19486
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。